CRISPR/Cas9-mediated deletion of Shp1 and Shp2 reveals distinct roles in human megakaryopoiesis and proplatelet formation
Eugénie Schaeffer, Elsa Barré, Desline Hennequin, Cécile Loubière, Léa Mallo, Catherine Strassel, Christian Andrea Di Buduo, Alessandra Balduini, Yotis A. Senis, Alexandra Mazharian
This study uses CRISPR/Cas9 to delete Shp1 and Shp2 in human CD34+ cells, showing Shp2 is critical for megakaryopoiesis and thrombopoiesis while Shp1 is not.
bioRxiv · Jul 24, 2026 · PreprintCell Biology